Hypoglycemia, functional brain failure, and brain death.
Open accessThe DOI matches its Crossref record; 18 of the 20 references it cites were found in a registry or an index.
Abstract
Hypoglycemia commonly causes brain fuel deprivation, resulting in functional brain failure, which can be corrected by raising plasma glucose concentrations. Rarely, profound hypoglycemia causes brain death that is not the result of fuel deprivation per se. In this issue of the JCI, Suh and colleagues use cell culture and in vivo rodent studies of glucose deprivation and marked hypoglycemia and provide evidence that hypoglycemic brain neuronal death is in fact increased by neuronal NADPH oxidase activation during glucose reperfusion (see the related article beginning on page 910). This finding suggests that, at least in the setting of profound hypoglycemia, therapeutic hyperglycemia should be avoided.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Glucose is an obligate metabolic fuel for the brain under physiological conditions (6,7).”
From Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline (2009) · cites this paper as [6]
In the citing paper
“use physiological circulating concentrations of alternative fuels effectively”
From Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline (2009) · cites this paper as [6]
In the citing paper
“Because the brain cannot synthesize glucose”
From Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline (2009) · cites this paper as [6]
In the citing paper
“store more than a few minutes' supply as glycogen”
From Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline (2009) · cites this paper as [6]
In the citing paper
“The behavioral defense is the ingestion of carbohydrates (6,7,12).”
From Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline (2009) · cites this paper as [6]
6 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Williams Textbook of Endocrinology
(2016) · Elsevier eBooks · doi:10.1016/c2013-0-15980-6 · Cited by 3,711
Brodie, S. E. (1996) · Survey of Ophthalmology · doi:10.1016/s0039-6257(96)80075-0 · Cited by 745
Circulation and Energy Metabolism of the Brain
Clarke, D. D., & Sokoloff, L. (1999) · Cited by 732
Laing, S. P., Swerdlow, A. J., Slater, S. D., Botha, J. L., Burden, A. C., Waugh, N. R., Smith, A. W. M., Hill, R. D., Bingley, P. J., Patterson, C. C., et al. (1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00075.x · Cited by 425
Suh, S. W., Gum, E. T., Hamby, A. M., Chan, P. H., & Swanson, R. A. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30077 · Cited by 419
Diverse causes of hypoglycemia-associated autonomic failure in diabetes.
Cryer, P. E. (2004) · New England Journal of Medicine · doi:10.1056/nejmra031354 · Cited by 411
Self-citationLactate: The Ultimate Cerebral Oxidative Energy Substrate?
Schurr, A. (2006) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600174 · Cited by 312
Laing, S. P., Swerdlow, A. J., Slater, S. D., Botha, J. L., Burden, A. C., Waugh, N. R., Smith, A. W. M., Hill, R. D., Bingley, P. J., Patterson, C. C., et al. (1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00076.x · Cited by 304
Suh, S. W., Aoyama, K., Chen, Y., Garnier, P., Matsumori, Y., Gum, E., Liu, J., & Swanson, R. A. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-33-10681.2003 · Cited by 211
Brain lactate kinetics: Modeling evidence for neuronal lactate uptake upon activation
Aubert, A., Costalat, R., Magistretti, P. J., & Pellerin, L. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505427102 · Cited by 207
Research works printed but not linked: 2
- Cryer, P.E. 2001. The prevention and correction of hypoglycemia. InHandbook of physiology. Section 7,The endocrine system. Volume 2,The endocrine pancreas and regulation of metabolism. L.S. Jefferson and A.D. Cherrington, editors. Oxford University Press. New York, New York, USA. 1057–1092.
- Cryer, P.E. 2003. Glucose homeostasis and hypoglycemia. InWilliams textbook of endocrinology. 10th edition. P.R. Larsen, H. Kronenberg, S. Melmed, and K. Polonsky, editors. Saunders/Elsevier. Philadelphia, Pennsylvania, USA. 1585–1618.
Cited by
Cryer, P. E., Axelrod, L., Grossman, A. B., Heller, S. R., Montori, V. M., Seaquist, E. R., & Service, F. J. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1410 · Cited by 1,277
Self-citationCryer, P. E., Davis, S. N., & Shamoon, H. (2003) · Diabetes Care · doi:10.2337/diacare.26.6.1902 · Cited by 1,160
Self-citationHypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus
Whitmer, R. A. (2009) · JAMA · doi:10.1001/jama.2009.460 · Cited by 1,128
Preiser, J.-C., Devos, P., Ruiz-Santana, S., Mélot, C., Annane, D., Groeneveld, J., Iapichino, G., Leverve, X., Nitenberg, G., Singer, P., et al. (2009) · Intensive Care Medicine · doi:10.1007/s00134-009-1585-2 · Cited by 911
The barrier of hypoglycemia in diabetes
Cryer, P. E. (2008) · Diabetes · doi:10.2337/db08-1084 · Cited by 725
“Rarely, it causes sudden, presumably cardiac arrhythmic death or, if it is profound and prolonged, brain death (13).”
BackgroundInfluentialSelf-citationThornton, P. S., Stanley, C. A., De Leon, D. D., Harris, D., Haymond, M. W., Hussain, K., Levitsky, L. L., Murad, M. H., Rozance, P. J., Simmons, R. A., et al. (2015) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2015.03.057 · Cited by 625
“9 mmol/L).(15) A further reduction of PG to 65-70 mg/dL (3.”
BackgroundJoshi, G. P., Chung, F., Vann, M. A., Ahmad, S., Gan, T. J., Goulson, D. T., Merrill, D. G., & Twersky, R. (2010) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e3181f9c288 · Cited by 298
“How Should We Identify and Manage Perioperative Hypoglycemia? Hypoglycemia may cause functional brain failure, and if profound or prolonged, can lead to brain death.(58) Occurrence of hypoglycemia is of great concern during general anesthesia and sedation, because the symptoms of hypoglycemia are masked.”
BackgroundThe relation of flow-experience and physiological arousal under stress — Can u shape it?
Peifer, C., Schulz, A., Schächinger, H., Baumann, N., & Antoni, C. H. (2014) · Journal of Experimental Social Psychology · doi:10.1016/j.jesp.2014.01.009 · Cited by 260
“Cortisol secretion enhances blood-glucose levels and provides additional energy resources to the individual in order to meet elevated energy demands during stress (Benedict et al., 2009; Cryer, 2007; Peters et al., 2004; Sapolsky, Romero, & Munck, 2000).”
BackgroundHypoglycemia: The neglected complication
Kalra, S., Mukherjee, J. J., Venkataraman, S., Bantwal, G., Shaikh, S., Saboo, B., Das, A. K., & Ramachandran, A. (2013) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.117219 · Cited by 255
“[47] Severe hypoglycemic episodes in older patients with diabetes have been shown to be associated with an increased risk of dementia,[48] functional brain failure[49] and cerebellar ataxia.”
BackgroundDynkevich, Y., Rother, K. I., Whitford, I., Qureshi, S., Galiveeti, S., Szulc, A. L., Danoff, A., Breen, T. L., Kaviani, N., Shanik, M. H., et al. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1033 · Cited by 224
“Similarly, Liu et al (107) developed an assay against pro– IGF-2 (69–84) and Tally et al (108) reported a radio-immunoassay for a 15–amino-acid segment of the E-domain.”
BackgroundMethodDevelopments in stem cell-derived islet replacement therapy for treating type 1 diabetes
Hogrebe, N. J., Ishahak, M., & Millman, J. R. (2023) · Cell Stem Cell · doi:10.1016/j.stem.2023.04.002 · Cited by 210
Cerebral ischemic damage in diabetes: an inflammatory perspective
Shukla, V., Shakya, A. K., Perez-Pinzon, M. A., & Dave, K. R. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0774-5 · Cited by 200
“Variety of other factors such as aging, patients with vascular disease or renal failure, pregnant women, and young T1D patients also contributes to the high risk of hypoglycemia [5, 18].”
BackgroundHypoglycemia in Type 1 Diabetes Mellitus
Cryer, P. E. (2010) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2010.05.003 · Cited by 205
“The concept of hypoglycemia-associated autonomic failure (HAAF) in diabetes [1,2,11,21] (Fig.”
BackgroundSelf-citationGlucose-Responsive Nanoparticles for Rapid and Extended Self-Regulated Insulin Delivery
Volpatti, L. R., Matranga, M. A., Cortinas, A. B., Delcassian, D., Daniel, K. B., Langer, R., & Anderson, D. G. (2020) · ACS Nano · doi:10.1021/acsnano.9b06395 · Cited by 189
Liu, J.-W., Luo, Y., Wang, Y.-M., Duan, L.-Y., Jiang, J.-H., & Yu, R.-Q. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b11207 · Cited by 185
Hypoglycemia: Still The Limiting Factor in the Glycemic Management of Diabetes
Cryer, P. E. (2008) · Endocrine Practice · doi:10.4158/ep.14.6.750 · Cited by 186
Self-citationMild hypoglycemia is independently associated with increased mortality in the critically ill
Krinsley, J. S., Schultz, M. J., Spronk, P. E., Harmsen, R. E., van Braam Houckgeest, F., van der Sluijs, J. P., Mélot, C., & Preiser, J. C. (2011) · Critical Care · doi:10.1186/cc10322 · Cited by 178
“These include the inhibition of insulin release, typically occurring when BG is lower than 80 mg/dl [26]; an increased release of glucagon, epinephrine and growth hormone when BG is lower than 65 mg/dl and increased release of cortisol when BG is lower than 55 mg/dl [27].”
BackgroundStem Cell-Derived, Fully Differentiated Islets for Type 1 Diabetes.
Reichman, T. W., Markmann, J. F., Odorico, J., Witkowski, P., Fung, J. J., Wijkstrom, M., Kandeel, F., de Koning, E. J. P., Peters, A. L., Mathieu, C., et al. (2025) · New England Journal of Medicine · doi:10.1056/nejmoa2506549 · Cited by 177
Hypoglycemia-associated mortality is not drug-associated but linked to comorbidities
Boucai, L., Southern, W. N., & Zonszein, J. (2011) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.07.011 · Cited by 175
pH-sensitive MOF integrated with glucose oxidase for glucose-responsive insulin delivery
Zhang, C., Hong, S., Liu, M.-D., Yu, W.-Y., Zhang, M.-K., Zhang, L., Zeng, X., & Zhang, X.-Z. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.01.038 · Cited by 165
The importance of hypoglycemia in diabetic patients
Shafiee, G., Mohajeri-Tehrani, M., Pajouhi, M., & Larijani, B. (2012) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/2251-6581-11-17 · Cited by 163
“Other hormones including glucagon and epinephrine are also secreted promptly after falling plasma glucose levels and both induce a rapid increase in glucose production [16].”
BackgroundInhibition of the mitochondrial pyruvate carrier protects from excitotoxic neuronal death
Divakaruni, A. S., Wallace, M., Buren, C., Martyniuk, K., Andreyev, A. Y., Li, E., Fields, J. A., Cordes, T., Reynolds, I. J., Bloodgood, B. L., et al. (2017) · Journal of Cell Biology · doi:10.1083/jcb.201612067 · Cited by 158
“In the healthy brain, substantial MPC inhibition could compromise cognitive JCB • Volume 216 • NumBer 4 • 20171100 function, indicated by the fact that arterial glucose can drop to only ∼40% of normal levels before loss of consciousness (Cryer, 2007).”
BackgroundInfluentialBio-Inspired Synthetic Nanovesicles for Glucose-Responsive Release of Insulin
Tai, W., Mo, R., Di, J., Subramanian, V., Gu, X., Buse, J. B., & Gu, Z. (2014) · Biomacromolecules · doi:10.1021/bm500364a · Cited by 158
Beeri, M. S., Schmeidler, J., Silverman, J. M., Gandy, S., Wysocki, M., Hannigan, C. M., Purohit, D. P., Lesser, G., Grossman, H. T., & Haroutunian, V. (2008) · Neurology · doi:10.1212/01.wnl.0000324925.95210.6d · Cited by 157
Noninvasive Electromagnetic Wave Sensing of Glucose
Zhang, R., Liu, S., Jin, H., Luo, Y., Zheng, Z., Gao, F., & Zheng, Y. (2019) · Sensors · doi:10.3390/s19051151 · Cited by 154
“Long-term abnormal levels of glucose (hyperglycemia when glucose level > 200 mg/dL [17] and hypoglycemia when glucose < 70 mg/dL [18]) often lead to complications including accelerated atherosclerosis [19], stroke [20], neuropathy [21], nephropathy [22], retinopathy [23] and et al.”
BackgroundNeuronal damage and cognitive impairment associated with hypoglycemia: An integrated view
Languren, G., Montiel, T., Julio-Amilpas, A., & Massieu, L. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.06.018 · Cited by 156
“…of glucose in blood fall to 2.5–3.5 mM (45–63 mg/dl) and include confusion, blurred vision, dizziness, irritability, difficulty to speak, feeling faint, drowsiness, difficulty of thinking, seizures and coma (Cryer, 2007; De Galan et al., 2006; Tesfaye and Seaquist, 2010; Warren and Frier, 2005).”
InfluentialZinc in the Brain: Friend or Foe?
Choi, S., Hong, D. K., Choi, B. Y., & Suh, S. W. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21238941 · Cited by 148
Cappellani, D., Macchia, E., Falorni, A., & Marchetti, P. (2020) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s219438 · Cited by 138
Death during intensive glycemic therapy of diabetes: mechanisms and implications
Cryer, P. E. (2011) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.08.008 · Cited by 137
Self-citationInsulin Therapy for the Management of Hyperglycemia in Hospitalized Patients
McDonnell, M. E., & Umpierrez, G. E. (2012) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2012.01.001 · Cited by 117
“1).(37,38) Glucose production is accomplished by gluconeogenesis or glycogenol-”
BackgroundA Tumor Agnostic Therapeutic Strategy for Hexokinase 1–Null/Hexokinase 2–Positive Cancers
Xu, S., & Herschman, H. R. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-1789 · Cited by 125
“For example, glucose insufficiency causes damage and death of brain cells (39).”
BackgroundAlam, F., Islam, M. A., Mohamed, M., Ahmad, I., Kamal, M. A., Donnelly, R., IDRIS, I. R., & Gan, S. H. (2019) · Scientific Reports · doi:10.1038/s41598-019-41854-2 · Cited by 133
Lee, A. K., Rawlings, A. M., Lee, C. J., Gross, A. L., Huang, E. S., Sharrett, A. R., Coresh, J., & Selvin, E. (2018) · Diabetologia · doi:10.1007/s00125-018-4668-1 · Cited by 115
Mao, Z., Qing, Z., Qing, T., Xu, F., Li, W., He, X., He, D., Shi, H., & Wang, K. (2015) · Analytical Chemistry · doi:10.1021/acs.analchem.5b01700 · Cited by 109
MANAGEMENT OF ENDOCRINE DISEASE: Pathogenesis and management of hypoglycemia
Kittah, N. E., & Vella, A. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-1062 · Cited by 107
Zecchin, C., Facchinetti, A., Sparacino, G., & Cobelli, C. (2013) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2013.09.016 · Cited by 114
Self-management Experience of Middle-aged and Older Adults With Type 2 Diabetes: A Qualitative Study
Wu, F., Tai, H., & Sun, J. (2019) · Asian Nursing Research · doi:10.1016/j.anr.2019.06.002 · Cited by 124
Acute ischaemic stroke: challenges for the intensivist
Smith, M., Reddy, U., Robba, C., Sharma, D., & Citerio, G. (2019) · Intensive Care Medicine · doi:10.1007/s00134-019-05705-y · Cited by 104
NADPH Oxidase 1, a Novel Molecular Source of ROS in Hippocampal Neuronal Death in Vascular Dementia
Choi, D.-H., Lee, K.-H., Kim, J.-H., Seo, J.-H., Kim, H. Y., Shin, C. Y., Han, J.-S., Han, S.-H., Kim, Y.-S., & Lee, J. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.5129 · Cited by 102
“The involvement of the Nox family in neuronal death was demonstrated under various conditions, such as exposure to zinc (37, 54), growth-factor deprivation (70), hypoglycemia (21, 67, 77), and N-methyl-D-aspartate (NMDA) activation (11).”
BackgroundERK2 Mediates Metabolic Stress Response to Regulate Cell Fate
Shin, S., Buel, G. R., Wolgamott, L., Plas, D. R., Asara, J. M., Blenis, J., & Yoon, S.-O. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.06.020 · Cited by 103
“A common example in which maintaining metabolic homeostasis is a struggle can occur in type 1 diabetics following insulin injection, which can result in plasma glucose concentrations of less than 1 mM (Cryer, 2007).”
Hamilton, A., Zhang, Q., Salehi, A., Willems, M., Knudsen, J. G., Ringgaard, A. K., Chapman, C. E., Gonzalez-Alvarez, A., Surdo, N. C., Zaccolo, M., et al. (2018) · Diabetes · doi:10.2337/db17-1102 · Cited by 94
“We tested the effect of adrenaline on glucagon secretion at a glucose concentration that roughly approximates hypoglycemia in vivo (3 mmol/L) (22) and minimizes the activity of b- and d-cells (see ref.”
BackgroundHome, P. D., Fritsche, A., Schinzel, S., & Massi‐Benedetti, M. (2010) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01232.x · Cited by 96
“In extreme cases, it can cause disablement and loss of consciousness, with risk of accidents and injuries [1,2].”
BackgroundMechchate, H., Es-safi, I., Haddad, H., Bekkari, H., Grafov, A., & Bousta, D. (2020) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2020.108520 · Cited by 102
Hou, L., Zheng, Y., Wang, Y., Hu, Y., Shi, J., Liu, Q., Zhang, H., & Zhang, Z. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b06998 · Cited by 93
An Overview of Hypoglycemia in the Critically Ill
Lacherade, J.-C., Jacqueminet, S., & Preiser, J.-C. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300603 · Cited by 86
Mild hypoglycemia is strongly associated with increased intensive care unit length of stay
Krinsley, J., Schultz, M. J., Spronk, P. E., van Braam Houckgeest, F., van der Sluijs, J. P., Mélot, C., & Preiser, J.-C. (2011) · Annals of Intensive Care · doi:10.1186/2110-5820-1-49 · Cited by 82
“Cryer has detailed the pathophysiologic consequences of hypoglycemia defined at this threshold [25].”
BackgroundPuhr, S., Derdzinski, M., Welsh, J. B., Parker, A. S., Walker, T., & Price, D. A. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0359 · Cited by 78
“Although the glucose threshold at which cognitive impairment is first detected or observed may vary between individuals, neuroglycopenic symptoms commonly occur at or <55 mg/dL.(8) Consensus statements have recommended that low threshold alerts be set at 70 mg/dL to provide patients enough time to intervene before neu…”
BackgroundElectroencephalography of Encephalopathy in Patients With Endocrine and Metabolic Disorders
Faigle, R., Sutter, R., & Kaplan, P. W. (2013) · Journal of Clinical Neurophysiology · doi:10.1097/wnp.0b013e3182a73db9 · Cited by 79
“Correction of hypoglycemia is usually accompanied by resolution of symptoms; however, occasional neurologic symptoms may linger even after reaching normoglycemia (Cryer, 2007).”
BackgroundXiao, N., Liu, S. G., Mo, S., Yang, Y. Z., Han, L., Ju, Y. J., Li, N. B., & Luo, H. Q. (2018) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2018.07.097 · Cited by 75
Alm-Kruse, K., Bull, E. M., & Laake, J. H. (2008) · BMC Nursing · doi:10.1186/1472-6955-7-1 · Cited by 72
“In a recent review, Cryer refers to laboratory work in non-human primates that demonstrated a need for prolonged (i.e. several hours) of severe hypoglycaemia ( 1.0 mmol/L) to reliably produce brain damage [21].”
InfluentialSajja, R. K., Green, K. N., & Cucullo, L. (2015) · PLOS ONE · doi:10.1371/journal.pone.0122358 · Cited by 69
“5–6 hours of such severe hypoglycemia were required to induce neurological damage [4].”
BackgroundHypoglycemia-associated autonomic failure in diabetes
Cryer, P. E. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-444-53491-0.00023-7 · Cited by 74
Self-citationHaces, M. L., Montiel, T., & Massieu, L. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.10.003 · Cited by 68
Cortisol effects on flow-experience
Peifer, C., Schächinger, H., Engeser, S., & Antoni, C. H. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3753-5 · Cited by 74
Karimian, N., Qin, T., Liang, T., Osundiji, M., Huang, Y., Teich, T., Riddell, M. C., Cattral, M. S., Coy, D. H., Vranic, M., et al. (2013) · Diabetes · doi:10.2337/db13-0164 · Cited by 66
A review of artificial pancreas technologies with an emphasis on bi‐hormonal therapy
Bakhtiani, P. A., Zhao, L. M., El Youssef, J., Castle, J. R., & Ward, W. K. (2013) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12107 · Cited by 65
“Severe hypoglycaemia can result in seizures, coma and if untreated, death [9], and for this reason, rapid-acting glucose (such as tablets, fruit juice or sweet snacks) or a glucagon emergency kit should always be available for those treated with insulin.”
Zhou, Z., Shi, G., Fontaine, R. E., Wei, K., Feng, T., Wang, F., Wang, G., Qu, Y., Li, Z., Dong, Z., et al. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201106502 · Cited by 65
Microgel encapsulated nanoparticles for glucose-responsive insulin delivery
Volpatti, L. R., Facklam, A. L., Cortinas, A. B., Lu, Y., Matranga, M. A., MacIsaac, C., Hill, M. C., Langer, R., & Anderson, D. G. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120458 · Cited by 68
Critical illness-induced dysglycemia and the brain
Sonneville, R., Vanhorebeek, I., den Hertog, H. M., Chrétien, F., Annane, D., Sharshar, T., & den Berghe, G. V. (2014) · Intensive Care Medicine · doi:10.1007/s00134-014-3577-0 · Cited by 82
“Transient hypoglycemia deprives the brain of its major fuel and may result in functional brain failure [32].”
Gerónimo-Olvera, C., Montiel, T., Rincon-Heredia, R., Castro-Obregón, S., & Massieu, L. (2017) · Cell Death & Disease · doi:10.1038/cddis.2017.299 · Cited by 64
“the hypoglycemic coma can occur resulting in brain injury if not opportunely reversed.(1) Hypoglycemia is the main complica-”
BackgroundPrediction and Prevention of Treatment-Related Inpatient Hypoglycemia
Elliott, M. B., Schafers, S. J., McGill, J. B., & Tobin, G. S. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600213 · Cited by 61
Oxygen and brain death; back from the brink
Bailey, D. M. (2019) · Experimental Physiology · doi:10.1113/ep088005 · Cited by 55
“Note the ‘critical’ arterial concentrations that serveaswarning signs of impending doom, below which substrate depletion pre- disposes to unconsciousness, coma and, ultimately, neuronal damage (Figure 3a; based on data cited by Bailey et al., 2017; Cryer, 2007).”
BackgroundNasraway, S. A. (2007) · Critical Care Medicine · doi:10.1097/01.ccm.0000286520.50104.51 · Cited by 52
Recognition, assessment and management of hypoglycaemia in childhood
Ghosh, A., Banerjee, I., & Morris, A. A. M. (2015) · Archives of Disease in Childhood · doi:10.1136/archdischild-2015-308337 · Cited by 48
Endocrine Autoimmune Disease as a Fragility of Immune Surveillance against Hypersecreting Mutants
Kohanim, Y. K., Tendler, A., Mayo, A., Friedman, N., & Alon, U. S. (2019) · Immunity · doi:10.1016/j.immuni.2020.04.022 · Cited by 49
Biochemical and genetic analyses of childhood attention deficit/hyperactivity disorder
Caylak, E. (2012) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32077 · Cited by 44
“inattentive ADHD subtype. Later, Kustanovich et al. [2004] repli-”
BackgroundHigh-performance ZnO nanowires-based glucose biosensor modified by graphene nanoplates
Rafiee, Z., Mosahebfard, A., & Sheikhi, M. H. (2020) · Materials Science in Semiconductor Processing · doi:10.1016/j.mssp.2020.105116 · Cited by 46
Qi, X., Xu, J., Chen, G., Liu, H., Liu, J., Wang, J., Zhang, X., Hao, Y., Wu, Q., & Jiao, M. (2021) · Health and Quality of Life Outcomes · doi:10.1186/s12955-021-01881-y · Cited by 48
“However, it might be dangerous to multi-vulnerable patients because it might result in hypoglycemia, causing dysfunctional osmolality and a range of consequences [62], including death [63].”
BackgroundGlucocorticoids, metabolism and brain activity
Jaszczyk, A., & Juszczak, G. R. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.03.007 · Cited by 49
Rosenstock, J., Fonseca, V., Schinzel, S., Dain, M.-P., Mullins, P., & Riddle, M. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.04.003 · Cited by 43
“Hypoglycemia is an important barrier to treatment for many patients with Type 2 diabetes mellitus (T2DM) — in particular, those with an extended duration of disease who receive insulin therapy (Cryer, 2007; Frier, 2008).”
BackgroundEvaluation and management of diabetic and non-diabetic hypoglycemia in end-stage renal disease
Gosmanov, A. R., Gosmanova, E. O., & Kovesdy, C. P. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv258 · Cited by 48
“Glucose is a necessary fuel for the brain under physiological states [11].”
BackgroundSleep and the response to hypoglycaemia
Jauch‐Chara, K., & Schultes, B. (2010) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2010.07.006 · Cited by 51
Saremi, A., Bahn, G. D., & Reaven, P. D. (2016) · Diabetes Care · doi:10.2337/dc15-2107 · Cited by 44
“9 mmol/L), is associated with acute activation of counterregulatory defense mechanisms and surges in the sympathoadrenal system, which increase cardiac workload, and provokes abnormal cardiac repolarization, vasospasm, and transient ischemia (11,12,22).”
Backgroundde Azevedo, J. R. A., de Araujo, L. O., da Silva, W. S., & de Azevedo, R. P. (2009) · Journal of Critical Care · doi:10.1016/j.jcrc.2008.10.011 · Cited by 43
“It is well documented that hypoglycemia is harmful to the central nervous system [14,15].”
BackgroundMughal, I. S., Patané, L., & Caponetto, R. (2024) · Annual Reviews in Control · doi:10.1016/j.arcontrol.2024.100937 · Cited by 46
Wang, C., Ahmed, M. M., Jiang, Q., Lu, N., Tan, C., Gao, Y., Mahmood, Q., Chen, D., Fukunaga, K., Li, M., et al. (2017) · Journal of Pineal Research · doi:10.1111/jpi.12440 · Cited by 43
Adrenal hormones mediate disease tolerance in malaria
Vandermosten, L., Pham, T., Knoops, S., Geest, C. D., Lays, N., der Molen, K. V., Kenyon, C. J., Verma, M., Chapman, K. E., Schuit, F. C., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06986-5 · Cited by 47
Dini, S., Zakeri, M., Ebrahimpour, S., Dehghanian, F., & Esmaeili, A. (2021) · Scientific Reports · doi:10.1038/s41598-021-87687-w · Cited by 42
Yanai, H., Adachi, H., Katsuyama, H., Moriyama, S., Hamasaki, H., & Sako, A. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i1.30 · Cited by 46
Perioperative Glucose Control in Neurosurgical Patients
Godoy, D. A., Napoli, M. D., Biestro, A., & Lenhardt, R. (2012) · Anesthesiology Research and Practice · doi:10.1155/2012/690362 · Cited by 44
“Finally, ADA can induce a more severe, prolonged, and often lethal hypoG in neurocritical patients [6, 7, 36, 37, 42].”
BackgroundGómora‐García, J. C., Gerónimo‐Olvera, C., Pérez-Martínez, X., & Massieu, L. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00518-9 · Cited by 40
In Defense of Sugar: A Critique of Diet-Centrism
Archer, E. (2018) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2018.04.007 · Cited by 44
Benedict, C., Kern, W., Schmid, S. M., Schultes, B., Born, J., & Hallschmid, M. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.10.010 · Cited by 37
“In fact, the HPA axis plays a key role in mobilizing energy resources in conditions of reduced energy supply (Peters et al., 2004; Cryer, 2007) such as during hypoglycemia (Radosevich et al.”
BackgroundNeural Metabolic Networks: Key Elements of Healthy Brain Function
Madrer, N., Perera, N. D., Uccelli, N. A., Abbondanza, A., Andersen, J. V., Carsana, E. V., Demmings, M. D., Fernandez, R. F., de Fragas, M. G., Gbadamosi, I., et al. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70084 · Cited by 37
“Thus, the brain is highly sensitive to energy shortages, a situation that becomes evident during hypoxia or hypoglycemia, which quickly impair neural function and lead to coma (Cryer 2007; Brownlee et al. 2020).”
Peyser, T. A., Nakamura, K., Price, D., Bohnett, L. C., Hirsch, I. B., & Balo, A. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0415 · Cited by 37
Oxidative stress: a common imbalance in diabetes and epilepsy
Ramos‐Riera, K. P., Pérez‐Severiano, F., & López‐Meraz, M. L. (2023) · Metabolic Brain Disease · doi:10.1007/s11011-022-01154-7 · Cited by 37
“…endocrine physiological defense mechanisms are activated to cope with hypoglycemia, such as a decreased insulin secretion by pancreatic beta cells, increased secretion of glucagon and epinephrine, and catabolism of glycogen stored in the liver and muscles to support brain function (Cryer 2007).”
BackgroundMethadone Use and the Risk of Hypoglycemia for Inpatients With Cancer Pain
Flory, J., Wiesenthal, A. C., Thaler, H. T., Koranteng, L. A., & Moryl, N. (2015) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2015.08.003 · Cited by 37
Glucose Homeostasis – Mechanism and Defects
Szablewski, L. (2011) · InTech eBooks · doi:10.5772/22905 · Cited by 49
“On the other hand, the brain cannot use fuels others than glucose during acute hypoglycemia [Cryer, 2001 a; Cryer, 2007; Wahren et al., 1999].”
BackgroundNeurocomputational Theories of Homeostatic Control
Hulme, O. J., Morville, T., & Gutkin, B. S. (2019) · Physics of Life Reviews · doi:10.1016/j.plrev.2019.07.005 · Cited by 42
“8 mmol/L) can cause cognitive impairment [46], seizure, coma [47], and ultimately death [48].”
BackgroundRhee, C. M., Kovesdy, C. P., You, A. S., Sim, J. J., Soohoo, M., Streja, E., Molnar, M. Z., Amin, A., Abbott, K. C., Nguyen, D. V., et al. (2018) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2018.04.022 · Cited by 35
Predictors of outcome in hypoglycemic encephalopathy
Ikeda, T., Takahashi, T., Sato, A., Tanaka, H., Igarashi, S., Fujita, N., Kuwabara, T., Kanazawa, M., Nishizawa, M., & Shimohata, T. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.05.007 · Cited by 32
“[4]).”
The double whammy of endogenous insulin antibodies in non-diabetic subjects
Ismail, A. A. (2007) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2008.031 · Cited by 30
“, the glycaemic threshold) pancreatic secretion decreases/ceases (8, 12, 16).”
BackgroundCell resilience in species life spans: a link to inflammation?
Finch, C. E., Morgan, T. E., Longo, V. D., & De Magalhaes, J. P. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00578.x · Cited by 29
“The level of glucose starvation in these studies (0.1–0.4 mg ml)1) was in the low clinical range of transient hypoglycemia that disturbs human cognition and behavior (< 0.50 mg ml)1, or < 50 mg dL)1, Cryer, 2007; Cryer et al., 2009).”
BackgroundInfluentialClinical Presentation and Diagnostic Approach to Hypoglycemia in Adults Without Diabetes Mellitus
Palani, G., Stortz, E., & Moheet, A. (2023) · Endocrine Practice · doi:10.1016/j.eprac.2022.11.010 · Cited by 29
The Energetic Collapse of the Alzheimer's Brain: Metabolic Inflexibility Across Cells and Networks
Constantino, N. J., Ashley, C. C., & Macauley, S. L. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70294 · Cited by 31
“For example, fasting or hypoglycemia restricts available fuels, while hyperglycemia and type-2 diabetes cause fuel excess-yet both can damage the brain (Carroll et al. 2022, 2024; Takeda et al. 2010; Xue et al. 2019; Lamy Christophe et al. 2014; Cryer 2007; Suh et al. 2007).”
Ali, A., Nouseen, S., Saroj, S., Shegane, M., Majumder, P., Puri, A., Rakshit, T., Manna, D., & Pal, S. (2022) · Journal of Materials Chemistry B · doi:10.1039/d2tb00603k · Cited by 29
Páramo, B., Montiel, T., Hernández-Espinosa, D. R., Rivera-Martínez, M., Morán, J., & Massieu, L. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.08.013 · Cited by 31
“Discussion Severe hypoglycemia leading to coma occurs most frequently in diabetic patients as a consequence of an insulin overdose and it can lead to permanent brain injury if not opportunely corrected (Cryer, 2007; Kalimo and Olsson, 1980).”
BackgroundHigh-glycolytic cancers and their interplay with the body’s glucose demand and supply cycle
Mathews, E. H., Liebenberg, L., & Pelzer, R. (2010) · Medical Hypotheses · doi:10.1016/j.mehy.2010.09.006 · Cited by 31
Ortiz, M. R. (2017) · Nursing Clinics of North America · doi:10.1016/j.cnur.2017.07.006 · Cited by 29
“Prolonged very low glucose levels can cause brain death.(14) In type 1 diabetes, this feedback mechanism is impaired.”
BackgroundAir‐Stable Perylene Diimide Trimer Material for N‐Type Organic Electrochemical Transistors
Nguyen-Dang, T., Bao, S. T., Kaiyasuan, C., Li, K., Chae, S., Yi, A., Joy, S., Harrison, K., Kim, J. Y., Pallini, F., et al. (2024) · Advanced Materials · doi:10.1002/adma.202312254 · Cited by 28
Metadata
- Authors
- Cryer, P. E.
- Affiliations
- Washington University in St. Louis (US)
- Corresponding author
- Cryer, Philip E.
- Venue
- Journal of Clinical Investigation
- Published
- 2007-04-02
- Volume
- 117
- Issue
- 4
- Pages
- 868-870
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC1838950
- OpenAlex
- W2060911425
- Semantic Scholar
- 383671055a18b86d57df354e9ed3bcde2efc6daa
- Cited by
- 363
- References
- 20
- Citations by year
- 2026: 20 · 2025: 22 · 2024: 25 · 2023: 25 · 2022: 23 · 2021: 22 · 2020: 24 · 2019: 25 · 2018: 23 · 2017: 14 · 2016: 15 · 2015: 21 · 2014: 17 · 2013: 20 · 2012: 19
- FWCI
- 6.85
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association
- National Institutes of Health (5p60dk020579-35, DK20579, P60-DK-20579, RR‐00036, T32 DK07120)
- National Institute of Diabetes and Digestive and Kidney Diseases (R37DK027085, P60-DK20579, R37-DK27085, T32 DK07120, P60-DK-020579, T32DK007120)
- National Center for Research Resources (M01-RR00036, M01RR000036)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Clinical Neurology › Neurological and metabolic disorders
- Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury and Neurovascular Disturbances
- Keywords
- hypoglycemia, brain death, glucose deprivation, neuronal cell death, NADPH oxidase
- MeSH terms
- Blood Glucose, Brain Death, Brain Diseases, Cognition Disorders, Humans, Hypoglycemia, Neurons
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.